Physiologically Based Pharmacokinetic (PBPK) Modeling to Predict PET Image Quality of Three Generations EGFR TKI in Advanced-Stage NSCLC Patients

Introduction: Epidermal growth factor receptor (EGFR) mutated NSCLC is best treated using an EGFR tyrosine kinase inhibitor (TKI). The presence and accessibility of EGFR overexpression and mutation in NSCLC can be determined using radiolabeled EGFR TKI PET/CT. However, recent research has shown a si...

Full description

Saved in:
Bibliographic Details
Main Authors: I. H. Bartelink (Author), E. A. van de Stadt (Author), A. F. Leeuwerik (Author), V. L. J. L. Thijssen (Author), J. R. I. Hupsel (Author), J. F. van den Nieuwendijk (Author), I. Bahce (Author), M. Yaqub (Author), N. H. Hendrikse (Author)
Format: Book
Published: MDPI AG, 2022-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available